0001179110-20-007493.txt : 20200617 0001179110-20-007493.hdr.sgml : 20200617 20200617160943 ACCESSION NUMBER: 0001179110-20-007493 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20200615 FILED AS OF DATE: 20200617 DATE AS OF CHANGE: 20200617 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Vandervoort Adam C CENTRAL INDEX KEY: 0001375088 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37477 FILM NUMBER: 20969823 MAIL ADDRESS: STREET 1: 485 MADISON AVENUE CITY: NEW YORK STATE: NY ZIP: 10022 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Teladoc Health, Inc. CENTRAL INDEX KEY: 0001477449 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011] IRS NUMBER: 043705970 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 BUSINESS PHONE: 2036352002 MAIL ADDRESS: STREET 1: 2 MANHATTANVILLE ROAD STREET 2: SUITE 203 CITY: PURCHASE STATE: NY ZIP: 10577 FORMER COMPANY: FORMER CONFORMED NAME: Teladoc, Inc. DATE OF NAME CHANGE: 20091123 4 1 edgar.xml FORM 4 - X0306 4 2020-06-15 0 0001477449 Teladoc Health, Inc. TDOC 0001375088 Vandervoort Adam C C/O TELADOC HEALTH, INC., 2 MANHATTANVILLE ROAD, SUITE 203 PURCHASE NY 10577 0 1 0 0 Chief Legal Officer, Secretary Common Stock 2020-06-15 4 M 0 1136 A 1336 D Common Stock 2020-06-15 4 S 0 547 175.57 D 789 D Common Stock 2020-06-16 4 S 0 589 184.81 D 200 D Restricted Stock Units 2020-06-15 4 M 0 1136 0.00 D Common Stock 1136 1136 D Shares sold to cover the issuer's withholding obligation in respect of reporting person's award. Restricted stock units convert to common stock on a one-for-one basis. On June 14, 2017, the reporting person was was granted 4,545 restricted stock units, vesting in four equal annual installments beginning on June 14, 2018. Each restricted stock unit represents a contingent right to receive one share of TDOC common stock. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 16, 2020. /s/ Adam C. Vandervoort 2020-06-16